Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-04-09 to 2025-04-10
Current total value of award: $22370.15
Description: 4567854213!XELJANZ XR 11 MG TABLET UU 30S